Comparison of three pharmaceutical products obtained from Mexico and the United States: A case study

Drug Development and Industrial Pharmacy

Volumn 31, Issue 10, 2005, Pages 993-1000

  Karlage, Kelly L ^a   Myrdal, Paul B ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Amoxicillin; Content uniformity; Foreign markets; Furosemide; Mexico

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; FUROSEMIDE;

ARTICLE; DRUG MARKETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; MEXICO; STANDARDIZATION; TABLET; UNITED STATES;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FUROSEMIDE; MEXICO; PHARMACEUTICAL PREPARATIONS; SUSPENSIONS; TABLETS; UNITED STATES;

EID: 28744448705     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500306245     Document Type: Article

References (12)

1. Calvillo, J. P., & Lal, L. (2003). Pilot study of a survey of U.S. residents purchasing medications in Mexico: demographics, reasons, and types of medications purchased. Clinical Therapeutics, 25(2), 561-577.
2. Casner, P. R., & Guerra, L. G. (1992). Purchasing prescription medication in Mexico without a prescription: the experience at the border. Western Journal of Medicine, 156(5), 512-516.
3. Davignon, J. P., Trissel, L. A., Kleinman, L. M., & Cradock, J. C. (1978). Pharmaceutical assessment of amygdalin (Laetrile) products. Cancer Treatment Reports, 62(1), 99-104.
4. Food and Drug Administration Consumer education: buying medicine from outside the United States. www.fda.gov/cder/consumerinfo/buy_outside_US_text. html (accessed Sept. 2004).
5. Food and Drug Administration. FDA warns consumers about counterfeit drugs purchased in Mexico. www.fda.gov/bbs/topics/ANSWERS/2005/ANS01 (accessed June 2005).
6. Hassan, M. A., Kaloustian, J., Prinderre, P., Ramsis, H., Khaled, K. A., El-faham, T. H., Tous, S. S., Maury, L., & Joachim, J. (1996). Physicochemical study on the interactions between amoxicillin trihydrate and some excipients used in solid dosage forms. Pharmazie, 51(6), 400-403.
7. Lopez, A. A., Garcia, C. R., Lapiedra, C. B., Dorantes, A. G., Jung, H. C., & Espejo, O. G. (1983). Comparative dissolution of solid pharmaceutical forms found on the Mexican drug market. I. Metronidazole. Revista de la Sociedad Química de México, 27(4), 164.
8. McKeithan, E. K., & Shepherd, M. D. (1996). Pharmaceutical products declared by U.S. residents on returning to the United States from Mexico. Clinical Therapeutics, 18(6), 1242-1251.
9. (2004a). The Official Compendia of Standards, USP 27/NSF 22. Rockville, MD: United States Pharmacopeial Convention, Inc., 138-143. Official Monographs.
10. (2004b). The Official Compendia of Standards, USP 27/NSF 22. Rockville, MD: United States Pharmacopeial Convention, Inc., 845-846. Official Monographs.
11. Singh, S., Rao, K. V. R., Venugopal, K., & Manikandan, R. (2002). Alteration in dissolution characteristics of gelatin-containing products: a review of the problem, test methods, and solutions. Pharmaceutical Technology, April. www.pharmtech.com (accessed Sept. 2004).
12. Trujillo, V. A., Herrera, P. Ma.D., Zamudio, A. R., Espinoza, R. M., & Luna, G. A. (2003). Herbal medicines and quality control. Revista Mexicana de Ciencias Farmacéuticas, 34(1), 22-27.